This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Reject Goldman Exec Pay Plan: Glass Lewis

Stocks in this article: GS JPM C MS

NEW YORK ( TheStreet) -- Influential shareholder proxy advisory firm Glass Lewis is advising shareholders of Goldman Sachs (GS) to vote against its executive compensation plan.

In a report Monday, the firm said the investment bank failed to align pay with performance, a concern it raised last year even though it ultimately approved last year's plan.

"Shareholders should be concerned with this disconnect particularly as this is the second year in a row the Company has paid more than its peers while performing somewhat worse, based on our pay for performance analysis," the report said. "A properly structured pay program should motivate executives to drive corporate performance, thus aligning executive and long-term shareholder interests."

"While we did not recommend shareholders vote against the Company's say on pay last year despite the misalignment of pay and performance, in light of the Company's continued failure to align executive pay with performance, as well as our serious concerns with the issues listed above, we believe shareholders should vote against the Company's executive compensation program," the report added.

Glass Lewis also once again recommended that shareholders vote against the election of director James Johnson, the chair of the compensation committee. The report highlighted Johnson's "poor history of oversight" as former CEO of bailed-out housing giant Fannie Mae (FNMA). During his tenure, the firm failed to account for $200 million in expenses allowing the executives to meet targets for maximum bonus payouts, the report noted.

Johnson has also held the role of a non-employee director at United Healthcare and KB Home (KBH). CEOs of both firms illegally backdated stock options.

Glass Lewis made a similar assessment in 2012. This year, "while the reputational risks to the Company decreased somewhat in 2012, we believe there has been no improvement in the Company's compensation practices," the report said. Instead, "the board has given itself a raise from already generous compensation levels."

The average director who served on Goldman Sachs' board throughout 2012 received $500,000 in compensation compared to less than $300,000 at JPMorgan (JPM), and $350,000 at Citigroup (C) and Morgan Stanley (MS).

For 2012, the board increased the amount of the annual equity grant to directors from 2,500 RSUS restricted stock units to 3,000 RSUs. Directors also received an annual retainer of $75,000 or 532 RSUs (at their election).

"In light of our concerns with the Company's compensation practices...and the aggregate compensation received by directors relative to peers, we think that shareholders should closely monitor the appropriateness of any future increases to director compensation," the report said.

-- Written by Shanthi Bharatwaj New York.

>Contact by Email.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs